# EDGAR Filing Document

**Accession Number:** 0001618921
**File Stem:** 9999999997-25-002535
**Filing Date:** 2025-6
**Character Count:** 2319
**Document Hash:** 4fcb502b5330f36a74f25e23bc26386e
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**9999999997-25-002535.hdr.sgml**: 20250606

**ACCESSION NUMBER**: 9999999997-25-002535

**CONFORMED SUBMISSION TYPE**: CT ORDER

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250606

**DATE AS OF CHANGE**: 20250605

**ACTION DATE**: 20250606

**RECEIVED DATE**: 20250605

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Walgreens Boots Alliance, Inc.
- **CENTRAL INDEX KEY:** 0001618921
- **STANDARD INDUSTRIAL CLASSIFICATION:** RETAIL-DRUG STORES AND PROPRIETARY STORES [5912]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 471758322
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0831

**FILING VALUES:**
- **FORM TYPE:** CT ORDER
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-88481
- **FILM NUMBER:** 251026512

**BUSINESS ADDRESS:**
- **STREET 1:** 108 WILMOT ROAD
- **CITY:** DEERFIELD
- **STATE:** IL
- **ZIP:** 60015
- **BUSINESS PHONE:** (847) 315-2500

**MAIL ADDRESS:**
- **STREET 1:** 108 WILMOT ROAD
- **CITY:** DEERFIELD
- **STATE:** IL
- **ZIP:** 60015

### Attached PDF Documents

**Attachment 1:** `filename1`

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
June 6, 2025

ORDER GRANTING CONFIDENTIAL TREATMENT
UNDER THE SECURITIES EXCHANGE ACT OF 1934

Walgreens Boots Alliance, Inc.

File No. 5-88481- CTR#8901

Walgreens Boots Alliance, Inc. submitted an application under Rule 24b-2 requesting confidential treatment for information it excluded from the Exhibits to a Schedule 13E-3/A filed on June 5, 2025.

Based on representations by Walgreens Boots Alliance, Inc. that this information qualifies as confidential commercial or financial information under the Freedom of Information Act, 5 U.S.C. 552(b)(4), the Division of Corporation Finance has determined not to publicly disclose it. Accordingly, excluded information from the following exhibits will not be released to the public:

- Exhibit (c)(1)
- Exhibit (c)(2)
- Exhibit (c)(3)
- Exhibit (c)(4)
- Exhibit (c)(5)
- Exhibit (c)(6)
- Exhibit (c)(7)
- Exhibit (c)(8)
- Exhibit (c)(9)
- Exhibit (c)(10)
- Exhibit (c)(11)
- Exhibit (c)(12)
- Exhibit (c)(13)
- Exhibit (c)(14)
- Exhibit (c)(15)

For the Commission, by the Division of Corporation Finance, pursuant to delegated authority:

Tiffany Posil
Chief, Office of Mergers and Acquisitions
Division of Corporation Finance